Welcome to LookChem.com Sign In|Join Free

CAS

  • or

96013-79-5

Post Buying Request

96013-79-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

96013-79-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 96013-79-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,6,0,1 and 3 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 96013-79:
(7*9)+(6*6)+(5*0)+(4*1)+(3*3)+(2*7)+(1*9)=135
135 % 10 = 5
So 96013-79-5 is a valid CAS Registry Number.

96013-79-5Relevant articles and documents

PROBE FOR DETECTING CARBAPENEM-RESISTANT BACTERIA AND USE THEREOF

-

Paragraph 0085; 0167-0169, (2021/09/10)

The present disclosure relates to a compound represented by Chemical Formula 1, a probe for detecting antibiotic-resistant bacteria, which includes the compound, a composition containing the compound, a kit including the compound and a method for detectin

Hafnium Triflate as a Highly Potent Catalyst for Regio- and Chemoselective Deprotection of Silyl Ethers

Zheng, Xiu-An,Kong, Rui,Huang, Hua-Shan,Wei, Jing-Ying,Chen, Ji-Zong,Gong, Shan-Shan,Sun, Qi

, p. 944 - 953 (2019/02/10)

As a Group IVB transition metal Lewis acid, hafnium triflate [Hf(OTf) 4 ] exhibited exceptionally high potency in desilylations. Since the amounts of Hf(OTf) 4 required for the deprotection of 1°, 2°, 3° alkyl and aryl tert -butyldimethylsilyl (TBS) ethers are significantly different, ranging from 0.05 mol% to 3 mol%, regioselective deprotection of TBS could be easily implemented. Moreover, chemoselective cleavage of different silyl ethers or removal of TBS in the presence of most hydroxyl protecting groups was also accomplished. NMR analyses of silyl products from TBS deprotection indicated that Hf(OTf) 4 -catalyzed desilylation may proceed via different mechanisms, depending on the solvent used.

PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS

-

, (2019/10/23)

The present disclosure provides, inter alia, Compounds of Formulae IA, IB, IC, IIA, IIB and IIC or pharmaceutically acceptable salts thereof that are modulators of the C5a receptor. Also provided are pharmaceutical compositions and methods of use including the treatment of diseases or disorders involving pathologic activation from C5a and non-pharmaceutical applications.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 96013-79-5